Gliquidone 33342-05-1
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehriger Ingelheim, Germany.
| Systematic (IUPAC) name: |
N-(cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide |
| Gliquidone CAS number: |
33342-05-1 |
| ATC code: |
A10BB08 |
| PubChem: |
91610 |
| DrugBank: |
|
| Formula: |
C27H33N3O6S |
| Molecular mass: |
527.634 g/mol |
| Gliquidone Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
